WST Insider Trading

Insider Ownership Percentage: 0.53%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $25,546,987.84

West Pharmaceutical Services Insider Trading History Chart

This chart shows the insider buying and selling history at West Pharmaceutical Services by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

West Pharmaceutical Services Share Price & Price History

Current Price: $203.00
Price Change: Price Decrease of -16.97 (-7.71%)
As of 04/4/2025 04:59 PM ET

This chart shows the closing price history over time for WST up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$203.00Closing price on 04/06/25:

SEC Filings (Institutional Ownership Changes) for West Pharmaceutical Services (NYSE:WST)

93.90% of West Pharmaceutical Services stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at WST by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$413ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1B-$500M$0$500M$1BTotal InflowsTotal Outflows
West Pharmaceutical Services logo
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Read More on West Pharmaceutical Services

Today's Range

Now: $203.00
Low: $202.86
High: $218.53

50 Day Range

MA: $251.41
Low: $199.40
High: $345.15

52 Week Range

Now: $203.00
Low: $197.01
High: $396.75

Volume

988,349 shs

Average Volume

673,536 shs

Market Capitalization

$14.68 billion

P/E Ratio

30.34

Dividend Yield

0.38%

Beta

1.22

Who are the company insiders with the largest holdings of West Pharmaceutical Services?

West Pharmaceutical Services' top insider investors include:
  1. Eric Mark Green (CEO)
  2. Thomas W Hofmann (Director)
  3. Quintin J Lai (VP)
  4. Annette F Favorite (VP)
  5. Silji Abraham (SVP)
  6. Bernard Birkett (SVP)
  7. Cindy Reiss-Clark (Insider)
  8. Charles Witherspoon (VP)
  9. Chad Winters (CAO)
Learn More about top insider investors at West Pharmaceutical Services.

Who are the major institutional investors of West Pharmaceutical Services?

West Pharmaceutical Services' top institutional investors include:
  1. First Hawaiian Bank — 0.01%
  2. MassMutual Private Wealth & Trust FSB — 0.00%
Learn More about top institutional investors of West Pharmaceutical Services stock.

Which major investors are selling West Pharmaceutical Services stock?

In the last quarter, WST stock was sold by these institutional investors:
  1. First Hawaiian Bank
  2. MassMutual Private Wealth & Trust FSB
During the previous year, company insiders that have sold West Pharmaceutical Services company stock include:
  1. Eric Mark Green (CEO)
  2. Thomas W Hofmann (Director)
  3. Quintin J Lai (VP)
  4. Annette F Favorite (VP)
Learn More investors selling West Pharmaceutical Services stock.